Durham-based Pappas Ventures seeks $125M to invest in biotech
A Durham-based company plans to raise $125 million to invest in biotechnology through a venture capital fund, according to a filing with the Securities and Exchange Commission. Pappas Ventures filed the Form D on Feb. 23. The first sale has yet to occur, with the proceeds not expected to last more than one year.
from Biotech News